Triple Therapy – PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration
Condition(s):Age Related Macular DegenerationLast Updated:May 27, 2010Completed
Hide Studies Not Open or Pending
Condition(s):Age Related Macular DegenerationLast Updated:May 27, 2010Completed
Condition(s):Age Related Macular Degeneration; AMD; CNVLast Updated:July 7, 2015Withdrawn
Condition(s):Geographic Atrophy; Age-related Macular DegenerationLast Updated:September 18, 2019Completed
Condition(s):Exudative Age-related Macular DegenerationLast Updated:March 24, 2015Completed
Condition(s):Age-Related Macular Degeneration; Retinal FunctionLast Updated:April 8, 2015Completed
Condition(s):Choroidal NeovascularizationLast Updated:December 31, 2015Withdrawn
Condition(s):AMD; Soft Drusen; Reticular Pseudodrusen; Drusen Stage Macular Degeneration; Drusen (Degenerative) of Macula, BilateralLast Updated:September 24, 2021Unknown status
Condition(s):AMD – Age-Related Macular Degeneration; Diabetic Macular EdemaLast Updated:November 12, 2020Completed
Condition(s):Neovascular Age Related Macular DegenerationLast Updated:September 22, 2020Completed
Condition(s):Macular DegenerationLast Updated:May 17, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.